Literature DB >> 12618763

The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour.

Ellen G Vernon1, Karim Malik, Paul Reynolds, Rachel Powlesland, Anthony R Dallosso, Sally Jackson, Karla Henthorn, Eric D Green, Keith W Brown.   

Abstract

Wilms' tumour (WT) has a diverse and complex molecular aetiology, with several different loci identified by cytogenetic and molecular analyses. One such locus is on chromosome 7p, where cytogenetic abnormalities and loss of heterozygosity (LOH) indicate the presence of a Wilms' tumour suppressor gene. In order to isolate a candidate gene for this locus, we have characterized the breakpoint regions at a novel constitutional chromosome translocation (t(1;7)(q42;p15)), found in a child with WT and skeletal abnormalities. We identified two genes that were interrupted by the translocation: the parathyroid hormone-responsive B1 gene (PTH-B1) at 7p and obscurin at 1q. With no evidence for LOH at 1q42, we focused on the characterization of PTH-B1. We detected novel alternately spliced isoforms of PTH-B1, which were expressed in a wide range of adult and foetal tissues. Importantly, expression of two isoforms were disrupted in the WT of the t(1;7) patient. We also identified an additional splice isoform expressed only in 7p LOH tumours. The disruption of PTH-B1 by the t(1;7), together with aberrant splicing in sporadic WTs, suggests that PTH-B1 is a candidate for the 7p Wilms' tumour suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618763     DOI: 10.1038/sj.onc.1206332

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 2.  Unraveling obscurins in heart disease.

Authors:  Alyssa Grogan; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Pflugers Arch       Date:  2018-08-11       Impact factor: 3.657

3.  Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene.

Authors:  Darryl Y Nishimura; Ruth E Swiderski; Charles C Searby; Erik M Berg; Amanda L Ferguson; Raoul Hennekam; Saul Merin; Richard G Weleber; Leslie G Biesecker; Edwin M Stone; Val C Sheffield
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

4.  Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma.

Authors:  Pei-Ming Song; Yang Zhang; Yu-Fei He; Hui-Min Bao; Jian-Hua Luo; Yin-Kun Liu; Peng-Yuan Yang; Xian Chen
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 5.  Obscurins: unassuming giants enter the spotlight.

Authors:  Nicole A Perry; Maegen A Ackermann; Marey Shriver; Li-Yen R Hu; Aikaterini Kontrogianni-Konstantopoulos
Journal:  IUBMB Life       Date:  2013-03-20       Impact factor: 3.885

6.  Knockdown of Bardet-Biedl syndrome gene BBS9/PTHB1 leads to cilia defects.

Authors:  Shobi Veleri; Kevin Bishop; Damian E Dalle Nogare; Milton A English; Trevor J Foskett; Ajay Chitnis; Raman Sood; Paul Liu; Anand Swaroop
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

Review 7.  Obscurin: A multitasking giant in the fight against cancer.

Authors:  Talia Guardia; Matthew Eason; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-18       Impact factor: 11.414

8.  Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci.

Authors:  Mark Stafford-Smith; Yi-Ju Li; Joseph P Mathew; Yen-Wei Li; Yunqi Ji; Barbara G Phillips-Bute; Carmelo A Milano; Mark F Newman; William E Kraus; Miklos D Kertai; Svati H Shah; Mihai V Podgoreanu
Journal:  Kidney Int       Date:  2015-06-17       Impact factor: 10.612

9.  Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.

Authors:  Kylie M Drake; E Cristy Ruteshouser; Rachael Natrajan; Phyllis Harbor; Jenny Wegert; Manfred Gessler; Kathy Pritchard-Jones; Paul Grundy; Jeffrey Dome; Vicki Huff; Chris Jones; Micheala A Aldred
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

10.  SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women.

Authors:  Liang-Chuan Lai; Mong-Hsun Tsai; Pei-Chun Chen; Lee H Chen; Jen-Hao Hsiao; Shin-Kuang Chen; Tzu-Pin Lu; Jang-Ming Lee; Chung-Ping Hsu; Chuhsing K Hsiao; Eric Y Chuang
Journal:  J Biomed Sci       Date:  2014-03-21       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.